肝病

订阅

MedSci主页 / 所有栏目 / 肝病

2012 EASL 酒精性肝病临床实践指南

2012-06-12 欧洲肝脏研究学会 J Hepatol

EASL酒精性肝病实践指南
关注

2012+EASL酒精性肝病的临床实践指南.pdf  

2012+EASL酒精性肝病的临床实践指南.pdf

 

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1673217, encodeId=397516e3217e9, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Tue Oct 16 05:27:00 CST 2012, time=2012-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1808061, encodeId=57e71808061e9, content=<a href='/topic/show?id=ff008125043' target=_blank style='color:#2F92EE;'>#肝病临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81250, encryptionId=ff008125043, topicName=肝病临床)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f32220, createdName=lancelotzzl, createdTime=Tue Jan 22 20:27:00 CST 2013, time=2013-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030965, encodeId=716e203096552, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Mon Sep 10 13:27:00 CST 2012, time=2012-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323582, encodeId=c03a132358297, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343674, encodeId=f15713436e42e, content=<a href='/topic/show?id=63ad95484f9' target=_blank style='color:#2F92EE;'>#酒精性肝病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95484, encryptionId=63ad95484f9, topicName=酒精性肝病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f2c2500194, createdName=446798725_87912765, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1412488, encodeId=f77b1412488e3, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6442, encryptionId=ebcd6442dc, topicName=EASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0c52872504, createdName=kord1983, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519140, encodeId=9aaa1519140e1, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2867, encryptionId=2082286e7b, topicName=ASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a311248160, createdName=lq1771, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571915, encodeId=a2a415e1915fa, content=<a href='/topic/show?id=413922e74cd' target=_blank style='color:#2F92EE;'>#临床实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22774, encryptionId=413922e74cd, topicName=临床实践指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=276d15780972, createdName=lily1621, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=)]
    2012-10-16 huiwelcome

    #酒精性#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1673217, encodeId=397516e3217e9, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Tue Oct 16 05:27:00 CST 2012, time=2012-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1808061, encodeId=57e71808061e9, content=<a href='/topic/show?id=ff008125043' target=_blank style='color:#2F92EE;'>#肝病临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81250, encryptionId=ff008125043, topicName=肝病临床)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f32220, createdName=lancelotzzl, createdTime=Tue Jan 22 20:27:00 CST 2013, time=2013-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030965, encodeId=716e203096552, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Mon Sep 10 13:27:00 CST 2012, time=2012-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323582, encodeId=c03a132358297, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343674, encodeId=f15713436e42e, content=<a href='/topic/show?id=63ad95484f9' target=_blank style='color:#2F92EE;'>#酒精性肝病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95484, encryptionId=63ad95484f9, topicName=酒精性肝病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f2c2500194, createdName=446798725_87912765, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1412488, encodeId=f77b1412488e3, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6442, encryptionId=ebcd6442dc, topicName=EASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0c52872504, createdName=kord1983, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519140, encodeId=9aaa1519140e1, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2867, encryptionId=2082286e7b, topicName=ASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a311248160, createdName=lq1771, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571915, encodeId=a2a415e1915fa, content=<a href='/topic/show?id=413922e74cd' target=_blank style='color:#2F92EE;'>#临床实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22774, encryptionId=413922e74cd, topicName=临床实践指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=276d15780972, createdName=lily1621, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=)]
    2013-01-22 lancelotzzl

    #肝病临床#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1673217, encodeId=397516e3217e9, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Tue Oct 16 05:27:00 CST 2012, time=2012-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1808061, encodeId=57e71808061e9, content=<a href='/topic/show?id=ff008125043' target=_blank style='color:#2F92EE;'>#肝病临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81250, encryptionId=ff008125043, topicName=肝病临床)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f32220, createdName=lancelotzzl, createdTime=Tue Jan 22 20:27:00 CST 2013, time=2013-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030965, encodeId=716e203096552, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Mon Sep 10 13:27:00 CST 2012, time=2012-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323582, encodeId=c03a132358297, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343674, encodeId=f15713436e42e, content=<a href='/topic/show?id=63ad95484f9' target=_blank style='color:#2F92EE;'>#酒精性肝病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95484, encryptionId=63ad95484f9, topicName=酒精性肝病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f2c2500194, createdName=446798725_87912765, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1412488, encodeId=f77b1412488e3, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6442, encryptionId=ebcd6442dc, topicName=EASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0c52872504, createdName=kord1983, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519140, encodeId=9aaa1519140e1, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2867, encryptionId=2082286e7b, topicName=ASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a311248160, createdName=lq1771, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571915, encodeId=a2a415e1915fa, content=<a href='/topic/show?id=413922e74cd' target=_blank style='color:#2F92EE;'>#临床实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22774, encryptionId=413922e74cd, topicName=临床实践指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=276d15780972, createdName=lily1621, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=)]
    2012-09-10 lvliquan

    #实践指南#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1673217, encodeId=397516e3217e9, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Tue Oct 16 05:27:00 CST 2012, time=2012-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1808061, encodeId=57e71808061e9, content=<a href='/topic/show?id=ff008125043' target=_blank style='color:#2F92EE;'>#肝病临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81250, encryptionId=ff008125043, topicName=肝病临床)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f32220, createdName=lancelotzzl, createdTime=Tue Jan 22 20:27:00 CST 2013, time=2013-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030965, encodeId=716e203096552, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Mon Sep 10 13:27:00 CST 2012, time=2012-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323582, encodeId=c03a132358297, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343674, encodeId=f15713436e42e, content=<a href='/topic/show?id=63ad95484f9' target=_blank style='color:#2F92EE;'>#酒精性肝病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95484, encryptionId=63ad95484f9, topicName=酒精性肝病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f2c2500194, createdName=446798725_87912765, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1412488, encodeId=f77b1412488e3, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6442, encryptionId=ebcd6442dc, topicName=EASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0c52872504, createdName=kord1983, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519140, encodeId=9aaa1519140e1, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2867, encryptionId=2082286e7b, topicName=ASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a311248160, createdName=lq1771, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571915, encodeId=a2a415e1915fa, content=<a href='/topic/show?id=413922e74cd' target=_blank style='color:#2F92EE;'>#临床实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22774, encryptionId=413922e74cd, topicName=临床实践指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=276d15780972, createdName=lily1621, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=)]
    2012-06-14 yanjie6253_56072842

    #临床实践#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1673217, encodeId=397516e3217e9, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Tue Oct 16 05:27:00 CST 2012, time=2012-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1808061, encodeId=57e71808061e9, content=<a href='/topic/show?id=ff008125043' target=_blank style='color:#2F92EE;'>#肝病临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81250, encryptionId=ff008125043, topicName=肝病临床)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f32220, createdName=lancelotzzl, createdTime=Tue Jan 22 20:27:00 CST 2013, time=2013-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030965, encodeId=716e203096552, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Mon Sep 10 13:27:00 CST 2012, time=2012-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323582, encodeId=c03a132358297, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343674, encodeId=f15713436e42e, content=<a href='/topic/show?id=63ad95484f9' target=_blank style='color:#2F92EE;'>#酒精性肝病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95484, encryptionId=63ad95484f9, topicName=酒精性肝病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f2c2500194, createdName=446798725_87912765, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1412488, encodeId=f77b1412488e3, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6442, encryptionId=ebcd6442dc, topicName=EASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0c52872504, createdName=kord1983, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519140, encodeId=9aaa1519140e1, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2867, encryptionId=2082286e7b, topicName=ASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a311248160, createdName=lq1771, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571915, encodeId=a2a415e1915fa, content=<a href='/topic/show?id=413922e74cd' target=_blank style='color:#2F92EE;'>#临床实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22774, encryptionId=413922e74cd, topicName=临床实践指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=276d15780972, createdName=lily1621, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=)]
    2012-06-14 446798725_87912765

    #酒精性肝病#

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1673217, encodeId=397516e3217e9, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Tue Oct 16 05:27:00 CST 2012, time=2012-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1808061, encodeId=57e71808061e9, content=<a href='/topic/show?id=ff008125043' target=_blank style='color:#2F92EE;'>#肝病临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81250, encryptionId=ff008125043, topicName=肝病临床)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f32220, createdName=lancelotzzl, createdTime=Tue Jan 22 20:27:00 CST 2013, time=2013-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030965, encodeId=716e203096552, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Mon Sep 10 13:27:00 CST 2012, time=2012-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323582, encodeId=c03a132358297, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343674, encodeId=f15713436e42e, content=<a href='/topic/show?id=63ad95484f9' target=_blank style='color:#2F92EE;'>#酒精性肝病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95484, encryptionId=63ad95484f9, topicName=酒精性肝病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f2c2500194, createdName=446798725_87912765, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1412488, encodeId=f77b1412488e3, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6442, encryptionId=ebcd6442dc, topicName=EASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0c52872504, createdName=kord1983, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519140, encodeId=9aaa1519140e1, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2867, encryptionId=2082286e7b, topicName=ASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a311248160, createdName=lq1771, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571915, encodeId=a2a415e1915fa, content=<a href='/topic/show?id=413922e74cd' target=_blank style='color:#2F92EE;'>#临床实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22774, encryptionId=413922e74cd, topicName=临床实践指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=276d15780972, createdName=lily1621, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=)]
    2012-06-14 kord1983

    #EASL#

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1673217, encodeId=397516e3217e9, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Tue Oct 16 05:27:00 CST 2012, time=2012-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1808061, encodeId=57e71808061e9, content=<a href='/topic/show?id=ff008125043' target=_blank style='color:#2F92EE;'>#肝病临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81250, encryptionId=ff008125043, topicName=肝病临床)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f32220, createdName=lancelotzzl, createdTime=Tue Jan 22 20:27:00 CST 2013, time=2013-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030965, encodeId=716e203096552, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Mon Sep 10 13:27:00 CST 2012, time=2012-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323582, encodeId=c03a132358297, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343674, encodeId=f15713436e42e, content=<a href='/topic/show?id=63ad95484f9' target=_blank style='color:#2F92EE;'>#酒精性肝病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95484, encryptionId=63ad95484f9, topicName=酒精性肝病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f2c2500194, createdName=446798725_87912765, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1412488, encodeId=f77b1412488e3, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6442, encryptionId=ebcd6442dc, topicName=EASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0c52872504, createdName=kord1983, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519140, encodeId=9aaa1519140e1, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2867, encryptionId=2082286e7b, topicName=ASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a311248160, createdName=lq1771, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571915, encodeId=a2a415e1915fa, content=<a href='/topic/show?id=413922e74cd' target=_blank style='color:#2F92EE;'>#临床实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22774, encryptionId=413922e74cd, topicName=临床实践指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=276d15780972, createdName=lily1621, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=)]
    2012-06-14 lq1771

    #ASL#

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1673217, encodeId=397516e3217e9, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95479, encryptionId=757b954e922, topicName=酒精性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=398f26933958, createdName=huiwelcome, createdTime=Tue Oct 16 05:27:00 CST 2012, time=2012-10-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1808061, encodeId=57e71808061e9, content=<a href='/topic/show?id=ff008125043' target=_blank style='color:#2F92EE;'>#肝病临床#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81250, encryptionId=ff008125043, topicName=肝病临床)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f32220, createdName=lancelotzzl, createdTime=Tue Jan 22 20:27:00 CST 2013, time=2013-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2030965, encodeId=716e203096552, content=<a href='/topic/show?id=5df2460e269' target=_blank style='color:#2F92EE;'>#实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46072, encryptionId=5df2460e269, topicName=实践指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=796422, createdName=lvliquan, createdTime=Mon Sep 10 13:27:00 CST 2012, time=2012-09-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1323582, encodeId=c03a132358297, content=<a href='/topic/show?id=42b922e7350' target=_blank style='color:#2F92EE;'>#临床实践#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22773, encryptionId=42b922e7350, topicName=临床实践)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=35fc2500023, createdName=yanjie6253_56072842, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1343674, encodeId=f15713436e42e, content=<a href='/topic/show?id=63ad95484f9' target=_blank style='color:#2F92EE;'>#酒精性肝病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=95484, encryptionId=63ad95484f9, topicName=酒精性肝病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4f2c2500194, createdName=446798725_87912765, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1412488, encodeId=f77b1412488e3, content=<a href='/topic/show?id=ebcd6442dc' target=_blank style='color:#2F92EE;'>#EASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6442, encryptionId=ebcd6442dc, topicName=EASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0c52872504, createdName=kord1983, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519140, encodeId=9aaa1519140e1, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2867, encryptionId=2082286e7b, topicName=ASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a311248160, createdName=lq1771, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1571915, encodeId=a2a415e1915fa, content=<a href='/topic/show?id=413922e74cd' target=_blank style='color:#2F92EE;'>#临床实践指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22774, encryptionId=413922e74cd, topicName=临床实践指南)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=276d15780972, createdName=lily1621, createdTime=Thu Jun 14 09:27:00 CST 2012, time=2012-06-14, status=1, ipAttribution=)]
    2012-06-14 lily1621

    #临床实践指南#

    0

相关资讯

[EASL2012]中国单元——“三首”亮相欧肝会

       【前言】第47届欧洲肝病研究学会年会，暨2012年国际肝脏大会，开幕的首日由中国北京大学医学部庄辉院士和EASL科学委员会成员、意大利亚历山德罗·曼佐尼医院（Ospedale Alessandro Manzoni）丹尼尔·普拉蒂（Daniele Prati）教授共同担任主持的“EASL-CHINA NETWORK”，成为此次

[EASL 2012]预测肝硬化程度新方法

       此次欧洲肝病研究学会第47届年会上，来自罗马尼亚的Simona Bota公布了一项全球性多中心研究的结果，该研究是针对转氨酶水平对声脉冲辐射力（ARFI）成像评估肝硬度与纤维化的相关性。Simona Bota等得出结论：在肝脏纤维化分期相同的情况下，ALT水平可能与肝脏硬度成正比。   &nbs

EASL/EORTC肝癌诊疗指南

　　日前，欧洲肝脏研究学会（EASL）与欧洲癌症治疗研究组织（EORTC）联合发布了肝癌诊疗指南。       原文链接：http://www.easl.eu/_clinical-practice-guideline 　　     

2009_EASL乙肝诊治指南

2009_EASL乙肝诊治指南.doc

EASL推出首部《HCV感染诊治指南》

　　　　 　　2011年3月3日，《肝脏病学杂志》（J Hepatol）在线发表了欧洲肝脏研究学会（EASL）的《丙型肝炎病毒（HCV）感染诊治指南》，这是EASL的首部关于HCV感染的指南，该指南采用的循证等级为GRADE系统，证据等级分为高质量（A）、中等质量（B）和低质量（C），推荐强度分为强推荐（1）和弱推荐（2）。我们邀请北京大学人民医院饶慧瑛及魏来向读者简要介绍该指南，并对该指南的特